In addition, the pro-carcinogenic effects of liraglutide on two highly aggressive breast cancer cell lines, MDA-MB-231 and MDA-MB-468, were most pronounced after 2 to 3 years of continuous exposure [18]
12 The editorials authors recommended the following: Consider holding the GLP-1 receptor agonist for at least 3 half-lives ahead of the procedure to clear approximately 88% of the drug
Antibody Blockade of activin type II receptors preserves skeletal muscle mass and enhances fat loss during GLP-1 receptor agonism
The semaglutide dosage for Rybelsus follows a specific titration
There was an increased number of thyroid cancers in the Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results (LEADER) clinical trial evaluating liraglutide versus placebo, but the risk did not reach statistical significance (hazard ratio [HR] 1.66, 95% CI 0.406.95), as well as in a meta-analysis of 12 other clinical trials with liraglutide (odds ratio [OR] 1.54, 95% CI 0.406.02) (7,8)
Researchers are still exploring the link between protein and GLP-1 production, and more human studies are ultimately needed
